Elanco is down -10.9%, or -$1.95 to $16.02.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco’s Governance Revamp, Board Changes, and Shareholder Decisions
- Elanco reports FDA confirmation that Bovaer meets safety, efficacy requirements
- Elanco price target raised to $19 from $18 at Piper Sandler
- Elanco Animal Health Stock (NYSE:ELAN): Hurdles Remain Despite Hitting 52-Week High
- Elanco price target raised to $20 from $18 at BofA